Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Burjeel HoldingsADX:BURJEEL -0.80%79 Return-on-Tangible-Equity is 9.86% as of Mar. 2026, which is 75% below its 10-year median of 40.14. GuruFocus rates ADX:BURJEEL with a GF Score™ of 79/100 and a GF Value™ of د.إ2.56 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 575 Healthcare Providers & Services companies, Burjeel Holdings ranks better than 73.91% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Burjeel Holdings's annualized net income for the quarter that ended in Mar. 2026 was د.إ199 Mil. Burjeel Holdings's average shareholder tangible equity for the quarter that ended in Mar. 2026 was د.إ2,013 Mil. Therefore, Burjeel Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 9.86%.
The historical rank and industry rank for Burjeel Holdings's Return-on-Tangible-Equity or its related term are showing as below:
ADX:BURJEEL'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 21.27 Med: 40.14 Max: 62.14
Current: 26.13
During the past 7 years, Burjeel Holdings's highest Return-on-Tangible-Equity was 62.14%. The lowest was 21.27%. And the median was 40.14%.
ADX:BURJEEL's Return-on-Tangible-Equity is ranked better than 73.91% of 575
companies
in the Healthcare Providers & Services industry
Industry Median: 10.56
vs ADX:BURJEEL: 26.13
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Burjeel Holdings Return-on-Tangible-Equity Related Terms
Burjeel Holdings Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Burjeel Holdings's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADX:BURJEEL vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Burjeel Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Burjeel Holdings Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Burjeel Holdings's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Burjeel Holdings's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 9.86% mean?
Burjeel Holdings (ADX:BURJEEL) has a Return-on-Tangible-Equity of 9.86% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Burjeel Holdings and its competitors. This is 75% below median its historical median of 40.14. Over the past decade, Burjeel Holdings' Return-on-Tangible-Equity has ranged from 21.27 to 62.14. According to the industry distribution chart, Burjeel Holdings ranks #150 out of 575 companies in the Healthcare Providers & Services industry, placing it in the top 26.1%.
Is Burjeel Holdings' Return-on-Tangible-Equity too high?
Burjeel Holdings' current Return-on-Tangible-Equity of 9.86% is 75% below median its 10-year median of 40.14. Over the past 10 years, this metric has ranged from a low of 21.27 to a high of 62.14. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.56. Burjeel Holdings' value of 9.86% is 6.6% below this industry median. Based on the distribution chart, Burjeel Holdings ranks #150 out of 575 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Burjeel Holdings has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Burjeel Holdings' Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Burjeel Holdings ranks #150 out of 575 companies for Return-on-Tangible-Equity. This puts Burjeel Holdings in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.56. Burjeel Holdings' value of 9.86% is 6.6% below this benchmark. Historically, Burjeel Holdings' own Return-on-Tangible-Equity has ranged from 21.27 to 62.14 over the past decade. While the company's 10-year median is 40.14 vs. the industry median of 10.56, Burjeel Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.56, based on 575 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Burjeel Holdings's current Return-on-Tangible-Equity of 9.86% is 6.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Burjeel Holdings and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Burjeel Holdings's current Return-on-Tangible-Equity is 9.86%, which is 75% below median its own 10-year median of 40.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Burjeel Holdings stock overvalued right now?
Based on GuruFocus' analysis, Burjeel Holdings (ADX:BURJEEL) is currently considered Significantly Undervalued. The stock's GF Value™ is د.إ2.56, compared to a current price of د.إ1.24 — trading 51.6% below its estimated fair value. The current Return-on-Tangible-Equity is 9.86%, which is 75% below median its 10-year median of 40.14 and 6.6% below the Healthcare Providers & Services industry median of 10.56. Burjeel Holdings' overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Burjeel Holdings (ADX:BURJEEL), the current Return-on-Tangible-Equity is 9.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Burjeel Holdings (ADX:BURJEEL) Overvalued in 2026?
Based on GuruFocus' analysis, Burjeel Holdings stock appears to be undervalued.
The current stock price of د.إ1.24 is trading 51.6% below its estimated GF Value™ of د.إ2.56.
GuruFocus considers Burjeel Holdings to be Significantly Undervalued.
Key valuation signals for ADX:BURJEEL:
Return-on-Tangible-Equity: 9.86% (75% below median its 10-year median of 40.14)
GF Value™: د.إ2.56 vs. price of د.إ1.24 (51.6% below fair value)
Industry Position: 6.6% below the Healthcare Providers & Services median (#150 of 575)
No single metric tells the full story. See the ADX:BURJEEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Burjeel Holdings PLC is a healthcare service provider. Along with its subsidiaries, it provides multi-specialty hospitals, medical, surgical and dental services, and the sale of pharmaceutical goods and medical equipment. The group's reportable segments are Hospitals, Medical Centre, Pharmacies, and Others. Maximum revenue for the group is derived from the Hospitals segment, which includes entities that provide inpatient, day-care services, and outpatient services to patients to diagnosis the disease and offer medical and surgical treatment as part of in-patient services. Geographically it derives maximum revenue from its customers in the United Arab Emirates, followed by the Sultanate of Oman and the Kingdom of Saudi Arabia.
79GF Score
Get the complete analysis for ADX:BURJEEL
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADX:BURJEEL has been successfully added to your 
